{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"gpuType":"T4","authorship_tag":"ABX9TyPdMtZMLSPwUh/S+vcQLyWa"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"},"accelerator":"GPU"},"cells":[{"cell_type":"code","execution_count":1,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"ndWHoOPQTWmM","executionInfo":{"status":"ok","timestamp":1754698827681,"user_tz":240,"elapsed":20683,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"ada9a904-35b7-4073-c73e-04eca200acca"},"outputs":[{"output_type":"stream","name":"stdout","text":["Mounted at /content/drive/\n"]}],"source":["from google.colab import drive\n","drive.mount('/content/drive/')"]},{"cell_type":"code","source":["%cd /content/drive/MyDrive/HRP/"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"DXWS4xMhgpJD","executionInfo":{"status":"ok","timestamp":1754698827864,"user_tz":240,"elapsed":189,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"9616cb41-a21b-4f40-b870-bc5b8408f20a"},"execution_count":2,"outputs":[{"output_type":"stream","name":"stdout","text":["/content/drive/MyDrive/HRP\n"]}]},{"cell_type":"code","source":["!ls"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"enI0U54JguS0","executionInfo":{"status":"ok","timestamp":1754698828438,"user_tz":240,"elapsed":573,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"8236b5f1-ea05-47a8-e782-a095e3055d0a"},"execution_count":3,"outputs":[{"output_type":"stream","name":"stdout","text":["extracted_pharmacy_notes.csv  unique_pharmacy_notes.csv\n"]}]},{"cell_type":"code","source":["!pip install gpt4all[cuda]"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"jnFUnnOPg-3E","executionInfo":{"status":"ok","timestamp":1754698868976,"user_tz":240,"elapsed":40546,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"d921b83f-4e9b-4705-9fb9-67d75d834373"},"execution_count":4,"outputs":[{"output_type":"stream","name":"stdout","text":["Collecting gpt4all[cuda]\n","  Downloading gpt4all-2.8.2-py3-none-manylinux1_x86_64.whl.metadata (4.8 kB)\n","Requirement already satisfied: requests in /usr/local/lib/python3.11/dist-packages (from gpt4all[cuda]) (2.32.3)\n","Requirement already satisfied: tqdm in /usr/local/lib/python3.11/dist-packages (from gpt4all[cuda]) (4.67.1)\n","Collecting nvidia-cuda-runtime-cu11 (from gpt4all[cuda])\n","  Downloading nvidia_cuda_runtime_cu11-11.8.89-py3-none-manylinux2014_x86_64.whl.metadata (1.5 kB)\n","Collecting nvidia-cublas-cu11 (from gpt4all[cuda])\n","  Downloading nvidia_cublas_cu11-11.11.3.6-py3-none-manylinux2014_x86_64.whl.metadata (1.5 kB)\n","Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests->gpt4all[cuda]) (3.4.2)\n","Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests->gpt4all[cuda]) (3.10)\n","Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests->gpt4all[cuda]) (2.5.0)\n","Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests->gpt4all[cuda]) (2025.8.3)\n","Downloading gpt4all-2.8.2-py3-none-manylinux1_x86_64.whl (121.6 MB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m121.6/121.6 MB\u001b[0m \u001b[31m7.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hDownloading nvidia_cublas_cu11-11.11.3.6-py3-none-manylinux2014_x86_64.whl (417.9 MB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m417.9/417.9 MB\u001b[0m \u001b[31m3.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hDownloading nvidia_cuda_runtime_cu11-11.8.89-py3-none-manylinux2014_x86_64.whl (875 kB)\n","\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m875.6/875.6 kB\u001b[0m \u001b[31m50.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n","\u001b[?25hInstalling collected packages: nvidia-cuda-runtime-cu11, nvidia-cublas-cu11, gpt4all\n","Successfully installed gpt4all-2.8.2 nvidia-cublas-cu11-11.11.3.6 nvidia-cuda-runtime-cu11-11.8.89\n"]}]},{"cell_type":"code","source":["import pandas as pd\n","import torch\n","from transformers import AutoTokenizer, AutoModelForTokenClassification, pipeline\n","from gpt4all import GPT4All\n","from pathlib import Path\n","from tqdm import tqdm"],"metadata":{"id":"GHHLdfDdhHk2","executionInfo":{"status":"ok","timestamp":1754698904700,"user_tz":240,"elapsed":35709,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}}},"execution_count":5,"outputs":[]},{"cell_type":"code","source":["model_dir = Path(r\"./\")\n","model_dir.mkdir(exist_ok=True)\n","\n","model = GPT4All(\n","    model_name=\"Meta-Llama-3-8B-Instruct.Q4_0.gguf\",\n","    model_path=model_dir,\n","    allow_download=True,\n","    n_threads=4,\n","    device=\"cuda\", # lets use that gpu\n","    ngl=100\n",")"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"V4NJPP66hSlr","executionInfo":{"status":"ok","timestamp":1754699061818,"user_tz":240,"elapsed":157125,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"b2b36dd9-496d-4d12-fb2b-d572cd9ad025"},"execution_count":6,"outputs":[{"output_type":"stream","name":"stderr","text":["Downloading: 100%|██████████| 4.66G/4.66G [01:52<00:00, 41.3MiB/s]\n","Verifying: 100%|██████████| 4.66G/4.66G [00:29<00:00, 160MiB/s]\n"]}]},{"cell_type":"code","source":["def make_prompt(text):\n","  prompt = (\n","      \"You are a medical expert. Extract dosages for all drugs: \"\n","      \"Return ONLY the following list [(drug,dosage,unit,frequency)] for each drug return nothing else at all\"\n","      f\"{text}\\nAnswer:\"\n","  )\n","  return prompt\n","\n","def extract_with_gpt4all(row, max_tokens=256):\n","    prompt = make_prompt(row[\"note_text\"])\n","\n","    response = model.generate(prompt, n_predict=max_tokens)\n","    return response.strip()"],"metadata":{"id":"TkdfE6C6hU9P","executionInfo":{"status":"ok","timestamp":1754699061850,"user_tz":240,"elapsed":21,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}}},"execution_count":7,"outputs":[]},{"cell_type":"code","source":["csv_path = \"unique_pharmacy_notes.csv\"\n","df = pd.read_csv(csv_path)\n","df.head()"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"v-tEJmMQhrJm","executionInfo":{"status":"ok","timestamp":1754699062612,"user_tz":240,"elapsed":756,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"c45fdad2-0515-4564-9a8c-8eca1106b349"},"execution_count":8,"outputs":[{"output_type":"execute_result","data":{"text/plain":["   note_row_id                                          note_text\n","0       314570  \"TITLE: PHARMACY\\n SEDATION\\n   Mr. [**Known l...\n","1       314572  \"TITLE: PHARMACY\\n SEDATION\\n   ASSESSMENT:\\n ...\n","2       314582  \"PHARMACY - VANCOMYCIN\\n   ASSESSMENT:\\n   Mr....\n","3       314707  \"PHARMACY\\n VANCO DOSING IN CRRT\\n   ASSESSMEN...\n","4       314739  \"Pharmacy Note\\n   TRANSITIONING and WEANING O..."],"text/html":["\n","  <div id=\"df-dfcd1656-5ade-420a-8eed-685075fb9bd9\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>note_row_id</th>\n","      <th>note_text</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>314570</td>\n","      <td>\"TITLE: PHARMACY\\n SEDATION\\n   Mr. [**Known l...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>314572</td>\n","      <td>\"TITLE: PHARMACY\\n SEDATION\\n   ASSESSMENT:\\n ...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>314582</td>\n","      <td>\"PHARMACY - VANCOMYCIN\\n   ASSESSMENT:\\n   Mr....</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>314707</td>\n","      <td>\"PHARMACY\\n VANCO DOSING IN CRRT\\n   ASSESSMEN...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>314739</td>\n","      <td>\"Pharmacy Note\\n   TRANSITIONING and WEANING O...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-dfcd1656-5ade-420a-8eed-685075fb9bd9')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-dfcd1656-5ade-420a-8eed-685075fb9bd9 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-dfcd1656-5ade-420a-8eed-685075fb9bd9');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-a5f0ae17-1dfd-478c-ab1e-c851daac9a50\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-a5f0ae17-1dfd-478c-ab1e-c851daac9a50')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-a5f0ae17-1dfd-478c-ab1e-c851daac9a50 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df","summary":"{\n  \"name\": \"df\",\n  \"rows\": 103,\n  \"fields\": [\n    {\n      \"column\": \"note_row_id\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 137702,\n        \"min\": 314570,\n        \"max\": 729201,\n        \"num_unique_values\": 103,\n        \"samples\": [\n          359659,\n          540802,\n          480246\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"note_text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"\\\"Cardiology Fellow Admit Addendum\\n   Please see CCU resident admit  note for complete details of HPI, PMH,\\n   Medications, SH/FH.\\n   In brief, this is a [**Age over 90 **] y.o. woman admitted originally for a hip\\n   fracture s/p ORIF, post-op course notable for electrolyte disarray,\\n   hospital-acquired pneumonia, and (starting [**3-16**]) typical atrial flutter\\n   with a slow ventricular response.  Initially managed on medicine\\n   service with EP consulting.  Strategy had been to observe her progress\\n   with all nodal agents witheld, as even with heart rates in the 40s she\\n   did not seem to have any symptoms referable to her arrhythmia.  Today\\n   her blood pressure dropped to the 80s/40s with HR still in the 40s,\\n   prompting transfer to the ICU for further care.\\n   On arrival to the unit, her BP had improved (without intervention) to\\n   90s-110s/50-60s.  DCCV was considered, but given relatively recent meal\\n   and encouraging BP, this was deferred.\\n   Impression\\n   [**Age over 90 **]f with atrial flutter, multi-level block and irregular ventricular\\n   response ranging high-30s to 60s.\\n   No need for urgent temporary pacing or DCCV now.\\n   Continue therapeutic anticoagulation.\\n   Plan for DCCV in the morning.  Hopefully this will provide a lasting\\n   response.  If not, given her overall preference to avoid invasive\\n   measures, would consider anti-arrhythmics to maintain sinus rhythm.\\n   Further plans as detailed by admitting resident note.\\n   Case discussed with Dr. [**Last Name (STitle) **].\\n   [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 4157**], M.D.\\n   x90493\\n\\\"\",\n          \"\\\"Pharmacy Note\\n Hypertension\\n   Assessment:\\n   Ms [**Known lastname 8257**] is currently being managed for neuroleptic malignant\\n   syndrome (NMS)  with dantrolene and benztropine and adjuncts.  She\\n   remains hypertensive on metoprolol IV and intermittent Hydralazine.\\n   Understandably, not able to use optimal drugs at this time to manage\\n   any components of delirium (e.g. haldol, Seroquel)\\n   Recommendation:\\n   Hypertension:\\n   Metoprolol may not help achieve goals given there is no alpha-blockade\\n which is often necessary in patients with such clinical status and\\n   history (e.g. alcohol, delirium, NMS). Hydralazine may result in\\n   rebound tachycardia.\\n   Labetalol may provide a better response if beta blockade is desirable\\n   since it brings both beta and alpha blockade. To initiate consider 10\\n   mg IV bolus followed by 2 mg/min infusion with supplemental 5 to 10 mg\\n   boluses q4hprn.  Getting this on board earlier will help avoid\\n   progressively higher blood pressures.\\n   Clonidine can be very useful in this population of patients as it\\n   provided blood pressure control with minimal effect on heart rate and\\n   acts on the central alpha receptors.  Would suggest 0.1 mg or 0.2 mg\\n   q6h or q4h standing.  To determine the dose give 0.1 mg and repeat in\\n   30 minutes if no response\\n this would suggest the patient needs 0.2 mg\\n   for example.  If no need to repeat the dose then her dose would be 0.1\\n   mg.  The frequency will be determined by how long the blood pressure is\\n   controlled.  She may require q4h scheduling of clonidine initially if\\n   the dose turns out to be 0.1 mg.\\n   Please contact with questions if need.\\n   [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **], PharmD\\n   Pager [**Numeric Identifier 499**]\\n\\\"\",\n          \"\\\"Pharmacy Note\\n Sedation\\n   Assessment:\\n   Currently on propofol 40 mcg/kg/minute with an order for\\n   dexmedetomidine (Precedex).\\n   Recommendation:\\n   Administer precedex loading dose (1 mCg/kg) over 10 to 30 minutes to\\n   avoid risk of hypotension.  I would recommend initiating the\\n   maintenance infusion at 0.7 mcg/kg/hr or higher given historic\\n   ineffectiveness of the lower doses recommended by the manufacturer\\n   package insert in the MICU population\\n lower precedex doses result in\\n   longer titration periods and prolonged patient discomfort and\\n   subsequent delay in extubation until the next day.\\n   When initiate the maintenance precedex infusion, please consider the\\n   following transition regimen:\\n   Start precedex infusion at 0.7 mcg/kg/hr\\n   Give one dose of haldol 5 mg IV or zyprexa 5 mg disintegrating tablet,\\n   wait ~ 30 minutes for this to take effect and then\\n   Turn off propofol so the patient should be covered with the\\n   antipsychotic and precedex\\n   Assess patient comfort every 15 minutes if possible to get rapid\\n   control with precedex which has rapid onset/clearance\\n   If precedex is not providing adequate comfort, adjust rate to 1\\n   micrograms/kg/hr for first uptitration and then 1.4 mcg/kg/hr for\\n   second uptitration.\\n   Give the pharmacokinetic profile of precedex, we should expect control\\n   with 2 hours of intiation\\n supplementing with haldol or zyprexa as\\n   needed for agitation.\\n   Please contact me if would like to discuss this complicated regimen.\\n   [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 1603**], PharmD\\n   Pager [**Numeric Identifier 1604**]\\n\\\"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":8}]},{"cell_type":"code","source":["tqdm.pandas(desc=\"Extracting with GPT4All\")\n","df[\"extraction\"] = df.progress_apply(extract_with_gpt4all, axis=1)\n","\n","df.to_csv(\"extracted_pharmacy_notes.csv\", index=False)"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"Il4uCk3ViQCN","executionInfo":{"status":"ok","timestamp":1754700582330,"user_tz":240,"elapsed":1519721,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"bc25477c-d1ce-47c3-bbcc-dbd7e1ff4e4d"},"execution_count":9,"outputs":[{"output_type":"stream","name":"stderr","text":["Extracting with GPT4All: 100%|██████████| 103/103 [25:19<00:00, 14.75s/it]\n"]}]},{"cell_type":"code","source":["df.head()"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"Lqufg4sGksCp","executionInfo":{"status":"ok","timestamp":1754700582386,"user_tz":240,"elapsed":64,"user":{"displayName":"owen wurst","userId":"16145957402126969890"}},"outputId":"593e29d4-3aa0-4a7d-aab7-bba6b2956487"},"execution_count":10,"outputs":[{"output_type":"execute_result","data":{"text/plain":["   note_row_id                                          note_text  \\\n","0       314570  \"TITLE: PHARMACY\\n SEDATION\\n   Mr. [**Known l...   \n","1       314572  \"TITLE: PHARMACY\\n SEDATION\\n   ASSESSMENT:\\n ...   \n","2       314582  \"PHARMACY - VANCOMYCIN\\n   ASSESSMENT:\\n   Mr....   \n","3       314707  \"PHARMACY\\n VANCO DOSING IN CRRT\\n   ASSESSMEN...   \n","4       314739  \"Pharmacy Note\\n   TRANSITIONING and WEANING O...   \n","\n","                                          extraction  \n","0  [(fentanyl,50 mcg/hr,hourly), (midazolam,2 mg/...  \n","1  [(drug, dosage, unit, frequency)]\\n[(fentanyl,...  \n","2  [(vancomycin,1000 mg,q48h)] Note that there is...  \n","3  [(Vancomycin,1 gram,PRN,\"\")]\\n([(Vancomycin,1 ...  \n","4  [(methadone,20mg,q6h),(lorazepam,2mg,four hour...  "],"text/html":["\n","  <div id=\"df-6898e7a2-9774-401d-81d0-a8cde7fd79a5\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>note_row_id</th>\n","      <th>note_text</th>\n","      <th>extraction</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>314570</td>\n","      <td>\"TITLE: PHARMACY\\n SEDATION\\n   Mr. [**Known l...</td>\n","      <td>[(fentanyl,50 mcg/hr,hourly), (midazolam,2 mg/...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>314572</td>\n","      <td>\"TITLE: PHARMACY\\n SEDATION\\n   ASSESSMENT:\\n ...</td>\n","      <td>[(drug, dosage, unit, frequency)]\\n[(fentanyl,...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>314582</td>\n","      <td>\"PHARMACY - VANCOMYCIN\\n   ASSESSMENT:\\n   Mr....</td>\n","      <td>[(vancomycin,1000 mg,q48h)] Note that there is...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>314707</td>\n","      <td>\"PHARMACY\\n VANCO DOSING IN CRRT\\n   ASSESSMEN...</td>\n","      <td>[(Vancomycin,1 gram,PRN,\"\")]\\n([(Vancomycin,1 ...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>314739</td>\n","      <td>\"Pharmacy Note\\n   TRANSITIONING and WEANING O...</td>\n","      <td>[(methadone,20mg,q6h),(lorazepam,2mg,four hour...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-6898e7a2-9774-401d-81d0-a8cde7fd79a5')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-6898e7a2-9774-401d-81d0-a8cde7fd79a5 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-6898e7a2-9774-401d-81d0-a8cde7fd79a5');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-8dc05fd4-3492-4e42-9bd1-19164c7423c6\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-8dc05fd4-3492-4e42-9bd1-19164c7423c6')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-8dc05fd4-3492-4e42-9bd1-19164c7423c6 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df","summary":"{\n  \"name\": \"df\",\n  \"rows\": 103,\n  \"fields\": [\n    {\n      \"column\": \"note_row_id\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 137702,\n        \"min\": 314570,\n        \"max\": 729201,\n        \"num_unique_values\": 103,\n        \"samples\": [\n          359659,\n          540802,\n          480246\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"note_text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"\\\"Cardiology Fellow Admit Addendum\\n   Please see CCU resident admit  note for complete details of HPI, PMH,\\n   Medications, SH/FH.\\n   In brief, this is a [**Age over 90 **] y.o. woman admitted originally for a hip\\n   fracture s/p ORIF, post-op course notable for electrolyte disarray,\\n   hospital-acquired pneumonia, and (starting [**3-16**]) typical atrial flutter\\n   with a slow ventricular response.  Initially managed on medicine\\n   service with EP consulting.  Strategy had been to observe her progress\\n   with all nodal agents witheld, as even with heart rates in the 40s she\\n   did not seem to have any symptoms referable to her arrhythmia.  Today\\n   her blood pressure dropped to the 80s/40s with HR still in the 40s,\\n   prompting transfer to the ICU for further care.\\n   On arrival to the unit, her BP had improved (without intervention) to\\n   90s-110s/50-60s.  DCCV was considered, but given relatively recent meal\\n   and encouraging BP, this was deferred.\\n   Impression\\n   [**Age over 90 **]f with atrial flutter, multi-level block and irregular ventricular\\n   response ranging high-30s to 60s.\\n   No need for urgent temporary pacing or DCCV now.\\n   Continue therapeutic anticoagulation.\\n   Plan for DCCV in the morning.  Hopefully this will provide a lasting\\n   response.  If not, given her overall preference to avoid invasive\\n   measures, would consider anti-arrhythmics to maintain sinus rhythm.\\n   Further plans as detailed by admitting resident note.\\n   Case discussed with Dr. [**Last Name (STitle) **].\\n   [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 4157**], M.D.\\n   x90493\\n\\\"\",\n          \"\\\"Pharmacy Note\\n Hypertension\\n   Assessment:\\n   Ms [**Known lastname 8257**] is currently being managed for neuroleptic malignant\\n   syndrome (NMS)  with dantrolene and benztropine and adjuncts.  She\\n   remains hypertensive on metoprolol IV and intermittent Hydralazine.\\n   Understandably, not able to use optimal drugs at this time to manage\\n   any components of delirium (e.g. haldol, Seroquel)\\n   Recommendation:\\n   Hypertension:\\n   Metoprolol may not help achieve goals given there is no alpha-blockade\\n which is often necessary in patients with such clinical status and\\n   history (e.g. alcohol, delirium, NMS). Hydralazine may result in\\n   rebound tachycardia.\\n   Labetalol may provide a better response if beta blockade is desirable\\n   since it brings both beta and alpha blockade. To initiate consider 10\\n   mg IV bolus followed by 2 mg/min infusion with supplemental 5 to 10 mg\\n   boluses q4hprn.  Getting this on board earlier will help avoid\\n   progressively higher blood pressures.\\n   Clonidine can be very useful in this population of patients as it\\n   provided blood pressure control with minimal effect on heart rate and\\n   acts on the central alpha receptors.  Would suggest 0.1 mg or 0.2 mg\\n   q6h or q4h standing.  To determine the dose give 0.1 mg and repeat in\\n   30 minutes if no response\\n this would suggest the patient needs 0.2 mg\\n   for example.  If no need to repeat the dose then her dose would be 0.1\\n   mg.  The frequency will be determined by how long the blood pressure is\\n   controlled.  She may require q4h scheduling of clonidine initially if\\n   the dose turns out to be 0.1 mg.\\n   Please contact with questions if need.\\n   [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **], PharmD\\n   Pager [**Numeric Identifier 499**]\\n\\\"\",\n          \"\\\"Pharmacy Note\\n Sedation\\n   Assessment:\\n   Currently on propofol 40 mcg/kg/minute with an order for\\n   dexmedetomidine (Precedex).\\n   Recommendation:\\n   Administer precedex loading dose (1 mCg/kg) over 10 to 30 minutes to\\n   avoid risk of hypotension.  I would recommend initiating the\\n   maintenance infusion at 0.7 mcg/kg/hr or higher given historic\\n   ineffectiveness of the lower doses recommended by the manufacturer\\n   package insert in the MICU population\\n lower precedex doses result in\\n   longer titration periods and prolonged patient discomfort and\\n   subsequent delay in extubation until the next day.\\n   When initiate the maintenance precedex infusion, please consider the\\n   following transition regimen:\\n   Start precedex infusion at 0.7 mcg/kg/hr\\n   Give one dose of haldol 5 mg IV or zyprexa 5 mg disintegrating tablet,\\n   wait ~ 30 minutes for this to take effect and then\\n   Turn off propofol so the patient should be covered with the\\n   antipsychotic and precedex\\n   Assess patient comfort every 15 minutes if possible to get rapid\\n   control with precedex which has rapid onset/clearance\\n   If precedex is not providing adequate comfort, adjust rate to 1\\n   micrograms/kg/hr for first uptitration and then 1.4 mcg/kg/hr for\\n   second uptitration.\\n   Give the pharmacokinetic profile of precedex, we should expect control\\n   with 2 hours of intiation\\n supplementing with haldol or zyprexa as\\n   needed for agitation.\\n   Please contact me if would like to discuss this complicated regimen.\\n   [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 1603**], PharmD\\n   Pager [**Numeric Identifier 1604**]\\n\\\"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"extraction\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 99,\n        \"samples\": [\n          \"[(fentanyl,100 mcg/hr,hr,\\\"-\\\"), (midazolam,4 mg/hr,hr,\\\"-\\\")]\\nNote that the dosages are in micrograms per hour for fentanyl and milligrams per hour for midazolam. The unit is hours for both drugs. There is no frequency specified other than \\\"day 5\\\" which likely refers to a day of treatment rather than a specific dosage schedule. \\nThe note does not mention any other dosages or frequencies, so there are only two entries in the list. \\n\\nPlease let me know if you have any further questions! \\nI am happy to help with anything else I can.  Thank you for your interest in my work.  Please do not hesitate to contact me if you require any additional assistance.\",\n          \"[(drug, dosage, unit, frequency)]\\n1. Midazolam, 3 mg/hr, hour, continuous\\n2. Lorazepam, 2 mg, none, q6h (initial)\\n3. Lorazepam, 2 mg, none, q8h (days 2-4)\\n4. Lorazepam, 2 mg, none, [**Hospital1**, days 5-7]\\n5. Lorazepam, as needed, none\\n6. Haloperidol, 5 mg, none, q6h or q4h\\n7. Olanzapine, same dose and frequency, none (alternative)\",\n          \"[(drug, dosage, unit, frequency)]\\n[(propofol, 45 mcg/kg/min, , )]\\n[(precedex, 1 mcg/kg/minute, , )]\\n[(precedex, 0.25 mcg/kg/min, , every 15 minutes)]\\n[(haldol, 5 mg, , q12hprn)]\\n[(zyprexa, 5 mg, , q12hprn)]\\n[(seroquel, 25 mg, , q12hprn)]\\\"Pharmacy Note   - Sedation\\n   Assessment:...\\n    Recommendation:\\n    1. Initiate the precedex drip at 1 mcg/kg/hour with no bolus preceding the drip.\\n    2. After the precedex has infused for 1 to 2 hours, turn off the propofol with no need to titrate down\\n    3. Then, titrate the precedex drip in increments of 0.25 mcg/kg/minute every 15 minutes (max dose is 1.4 mcg/kg/min) and monitor patient response during the transition period.\\n    4. Precedex can be infused before, during and after extubation with no risk of respiratory depression in\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":10}]}]}